| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -30,911 | -19,187 | -7,254 | -13,650 |
| Earnings per share, basic | -2.18 | -2.45 | -1.5 | -0.32 |
| Earnings per share, diluted | -2.18 | -2.45 | -1.5 | -0.32 |
| Weighted average number of shares outstanding, basic | 14,196,000 | 7,843,000 | 4,834,000 | 42,390,000 |
| Weighted average number of shares outstanding, diluted | 14,196,000 | 7,843,000 | 4,834,000 | 42,390,000 |
BioXcel Therapeutics, Inc. (BTAI)
BioXcel Therapeutics, Inc. (BTAI)